Objective: The aim of the study was to evaluate the clinical audiological outcomes as well as patient satisfaction following implantation with Cochlear™ Osia® System . Patients and Methods: This is a proospective clinical study. A total of 21 patients who underwent the Cochlear™ Osia® surgery were analysed for audiological outcomes, surgical complications, and device-related postoperative follow-up. Speech recognition performance and hearing aided thresholds with and without device conditions were evaluated. Results: The surgical procedure and healing were uneventful. Statistically significant improvements in audibility and speech understanding recorded for the test device compared with pre-operative unaided hearing. The overall mean for the gain in frequencies 0.5 to 4 kHz was 35 dB. On average, the speech discrimination scores improved by 36% post-operatively. Good soft tissue outcomes were reported, without major soft tissue related complications. At the end of the investigation, all patients continued to use and benefit from the device. Conclusions: The Osia bone conduction device provides good outcomes in patients with a conductive, mixed, or single-sided sensorineural hearing loss.

Auditory and Speech Performance in Patients following Cochlear™ Osia® System IMPLANTATION

It is with great pleasure and enthusiasm, that on behalf of the Cochlear Implant centers of the Radboud UMC in Nijmegen and Erasmus MC Sophia Children’s Hospital in Rotterdam to invite you to attend the 16th European Symposium on Pediatric Cochlear Implantation to Rotterdam, the Netherlands in 2023.

Yours sincerely, on behalf of the CI Centers at Radboud UMC and Erasmus MC,